Open original FDA record ↗Recall record
- FDA identifier
- Z-1297-2014
- Company in FDA record
- Trivascular, Inc
- FDA classification date
- Mar 26, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Communication to European physician users of the Ovation Prime Abdominal Stent Graft system to notify them of changes to Instructions for Use.
Source facts
- Action
- Trivascular sent an Important Medical Device Information letter dated February 27, 2014, to all European physicians who have scheduled cases through March 31, 2014 or until IFU;s are translated and available for European physicians. The letter provided notification of an update that will appear in a future revision of the product Instructions for Use (IFU). The IFU will be available in their country when the required translations and product registration/notification have been completed. This IFU does not require rework or return of the affected product. Customers with questions were instructed to contact their local TriVascular representative. For questions regarding this recall call 707-543-8805.
- Initiated
- 2014-02-27
- Root cause
- Device Design
- Terminated
- 2014-04-11
- Distribution
- Worldwide Distribution including Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Italy, Luxembourg, Norway, Poland, Spain, and Sweden.
- Recall number
- Z-1297-2014
- Recall status
- Terminated
- CDRH record ID
- 126008
- FDA classified
- 2014-03-26
- Recall event number
- 67672